Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Novartis

This publication has 30 references indexed in Scilit: